Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alcoholism: early-phase trial registry
11 of 67 indexed Alcoholism trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #208 of 28,707 conditions by registered trial count.
67 US clinical trials · 11 currently recruiting · #208 of 28,707 conditions by registered trial count
Alcoholism: 67 US clinical trials tracked, 11 recruiting.
Alcoholism is the subject of 67 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 14 are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), running 11 of these trials.
Enrollment posture brief
Registry condition alcoholism
OPEN 11 | RECR 16% | LATE 14 | EARLY 26 | RANK #208 | SPON 11
Volume-matched condition peers
Nearest open-share peer: Stage IVA Lung Cancer AJCC v8 (16% recruiting · 37 trials)
Alcoholism lists 11 open slots (16% of 67 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alcoholism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alcoholism is recruiting below its size-band peers.
11 of 67 indexed trials (16.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Alcoholism research.
National Institute on Alcohol Abuse and Alcoholism (NIAAA) accounts for 11 of 67 trials (16.4%). 34 distinct sponsors appear on at least one study for this condition label.
-
Typical Alcoholism enrolment sits around 120 participants.
Median target enrolment is 120 among the 66 trials that report a genuine target (sentinel values excluded). 30 of those (45.5%) plan for fewer than 100 participants.
-
Alcoholism research is mostly interventional.
56 interventional and 11 observational studies make up this index (83.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
67 total, page 2 of 2
Neural Substrates of Approach-Avoidance Conflict
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT02119624
Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.
University of Pennsylvania
NCT00124059
Naltrexone for Relapse Prevention
UConn Health
NCT00000442
N-acetylcysteine in Alcohol Dependence
Minneapolis Veterans Affairs Medical Center
NCT00568087
Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
UConn Health
NCT00802321
Zonisamide vs. Placebo in the Treatment of Alcohol Dependence
UConn Health
NCT00595556
The Effects of Levetiracetam on Alcohol Dependent Subjects
Boston University
NCT00325182
Baclofen for Treating Anxiety and Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT01751386
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
Brown University
NCT01504295
EMPOWER AUD Pivotal Trial
Theranova, L.L.C.
NCT05948605
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study
National Institute on Drug Abuse (NIDA)
NCT03152760
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
Northwell Health
NCT02885311
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
Virginia Commonwealth University
NCT02120365
A Novel Compound for Alcoholism Treatment
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT02039349
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Northwell Health
NCT01208311
GSK1521498 Alcohol Interaction Study
GlaxoSmithKline
NCT01366573
Ondansetron Treatment for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT00000443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 16 |
| Phase 3 | 3 |
| Phase 4 | 11 |
Top Sponsors
Named interventions
Most-linked intervention names on Alcoholism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alcoholism trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alcoholism page
67 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Alcoholism trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) sponsors the most Alcoholism trials on record, review their full trial history before evaluating a specific study. See National Institute on Alcohol Abuse and Alcoholism (NIAAA)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alcoholism condition card totals 67 registered trials; most-linked intervention Placebo; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.